ArticleJournal of breast cancer2012

Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.

Li-Heng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.